CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Trospium chloride

Last Updated: March 24, 2006
Result type: Reports
Project Number: SR0055-000
Product Line: Reimbursement Review

Generic Name: Trospium chloride

Brand Name: Trosec

Manufacturer: Oryx Pharmaceuticals Inc.

Therapeutic Area: Bladder, overactive

Indications: Bladder, overactive

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: August 24, 2006

Recommendation Type: List with clinical criteria and/or conditions